CLQHF - G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER WORKING STRENGT
- MSDS: CLQHF
- Manufacturer: AGFA CORP
- Product Name: G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER WORKING STRENGT
- National Stock Number: 6750-01-461-5235
Product Identification
Product ID:G-135 INDUSTRIAL X-RAY DEVELOPER/REPLENISHER WORKING STRENGT
MSDS Date:03/24/2000
FSC:6750
NIIN:01-461-5235
Status Code:A
Kit Part:Y
MSDS Number: CLQHF
Responsible Party
RIDGEFIELD PARK, NJ 07660
US
Emergency Phone: (303) 623-5716 HEALTH
Info Phone: 201-440-2500
Preparer: S. VAN VOLKENBURG
Cage: 1MVW0
Contractor
Telephone: 201-440-2500
Cage: 1MVW0
Ingredients
POTASSIUM GLUTARALDEHYDE BISULFITE (1,5-PENTANEDISULFONIC
CAS: 68310-08-7
POTASSIUM SULFITE
CAS: 10117-38-1
HYDROQUINONE
CAS: 123-31-9
RTECS: MX3500000
OSHA PEL 2 MG/M3
ACGIH TLV: 2 MG/M3
EPA Report Quantity: 1 LB
DOT Report Quantity: 1 LB
SODIUM TETRABORATE
CAS: 1303-96-4
RTECS: VZ2275000
ACGIH TLV: 5 MG/M3
Hazards
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:ACUTE: EXPOSURE MAY CAUSE EYE, SKIN &
RESPIRATORY TRACT IRRITATION. MAY CAUSE ALLERGIC SKIN REACTION.
INGESTION MAY BE HARMFUL AND CAUSE IRRITATION OF GI TRACT. SULFITE
SENSITIVE PERSONS MAY SUFFER AL LERGIC REACTION. CHRONIC:
PROLONGED/ REPEATED EXPOSURE MAY CAUSE SKIN SENSITIZATION/
DERMATITIS, ANEMIA, INTOLERANCE TO LIGHT, CORNEAL PIGMENTATION,
SOME ASTHMATICS AND SULFITE SENSITIVE PERSONS MAY S UFFER ALLERGIC
REACTIONS.
Explanation of Carcinogenicity:THE COMPONENTS OF THIS PRODUCT ARE NOT
LISTED BY NTP, IARC OR REGULATED AS A CARCINOGEN BY OSHA.
Effects of Overexposure:ACUTE INHALATION: MAY CAUSE IRRITATION WITH
SYMPTOMS OF COUGHING, SORE THROAT, AND RUNNY NOSE. CHRONIC
INHALATION: SULFITES MAY CAUSE AN ALLERGIC REACTION IN SOME
ASTHMATICS AND SULFITE SENSITIVE IN DIVIDUALS. POSSIBLE SYMPTOMS
INCLUDE BRONCHOCONSTRICTION, SWEATING, FLUSHING, HIVES, RAPID HEART
RATE, DECREASED BLOOD PRESSURE, AND ANAPHYLAXIS. PROLONGED
INHALATION MAY CAUSE SKIN ERUPTIONS. ACUTE S KIN CONTACT: MAY BE
IRRITATING TO THE SKIN WITH SYMPTOMS OF REDDENING AND ITCHING.
INGESTION: NAUSEA, VOMITING, DROWSINESS, STOMACHACHE.
Medical Cond Aggravated by Exposure:PERSONS WITH PREEXISTING EYE OR
SKIN CONDITIONS OR IMPAIRED PULMONARY FUNCTION MAY BE MORE
SUSCEPTIBLE TO THE EFFECTS OF THIS PRODUCT.
First Aid
First Aid:EYE: IMMEDIATELY FLUSH EYES WITH PLENTY OF WATER FOR AT LEAST
15 MINUTES. CALL A PHYSICIAN. SKIN: REMOVE CONTAMINATED CLOTHING,
IMMEDIATELY WASH SKIN WITH PLENTY OF WATER. WASH CLOTHING BEFORE
REUSE. CALL A PHYSICIAN IF IRRITATION PERSISTS. INHALATION:
REMOVE TO FRESH AIR. IF NOT BREATHING, GIVE ARTIFICIAL RESPIRATION.
IF BREATHING IS DIFFICULT, GIVE OXYGEN. CALL A PHYSICIAN.
INGESTION: DRINK 1-2 GLASSES OF WATER. NEVER GIVE ANYTHING BY
MOUTH TO AN UNCONSCIOUS PERSON. SEEK MEDICAL ATTENTION. TAKE THIS
MSDS TO PHYSICIAN.
Fire Fighting
Flash Point:NONCOMBUSTIBLE
Extinguishing Media:MATERIAL IS NOT COMBUSTIBLE. USE EXTINGUISHING
MEDIA SUITABLE FOR OTHER COMBUSTIBLE MATERIALS IN THE AREA.
Fire Fighting Procedures:EVACUATE PERSONNEL TO A SAFE AREA. KEEP
PERSONNEL REMOVED AND UPWIND OF FIRE. WEAR SELF-CONTAINED BREATHING
APPARATUS.
Accidental Release
Spill Release Procedures:USE APPROPRIATE PERSONAL PROTECTIVE EQUIPMENT
DURING CLEAN UP. DIKE SPILL. PREVENT LIQUID FROM ENTERING SEWERS,
WATERWAYS OR LOW AREAS. SOAK UP WITH SAWDUST, SAND, OIL DRY OR
OTHER ABSORBENT MATERIAL. SPILL MAY BE NEUTRALIZED WITH POWDERED
CITRIC ACID.
Neutralizing Agent:SPILL MAY BE NEUTRALIZED WITH POWDERED CITRIC ACID.
Handling
Handling and Storage Precautions:STORE BETWEEN 40F (4.4C) AND 80F
(26C). PREFERRED STORAGE IS AT 68F (20C). KEEP FROM FREEZING. AVOID
EYE AND SKIN CONTACT, AND STORE IN WELL-VENTILATED AREA. KEEP
CONTAINER TIGHTLY CLOSED. DO NOT STOR E WITH INCOMPATIBLE
MATERIALS.
Other Precautions:DO NOT STORE OR CONSUME FOOD, DRINK OR TOBACCO IN
AREA WHERE THEY MAY BECOME CONTAMINATED WITH THIS MATERIAL. KEEP
OUT OF REACH OF CHILDREN.
Exposure Controls
Respiratory Protection:UNDER NORMAL CONDITIONS OF USE, RESPIRATOR
PROTECTION IS NOT REQUIRED. IF RESPIRATORS ARE USED, INSTITUTE A
PROGRAM IN ACCORDANCE WITH OSHA STANDARD 29CFR1010.134.
Ventilation:USE SUFFICIENT GENERAL ROOM VENTILATION AND/OR LOCAL
EXHAUST TO MAINTAIN AIRBORNE LEVELS OF VAPORS BELOW APPLICABLE
EXPOSURE LIMITS.
Protective Gloves:USE CHEMICAL RESISTANT GLOVES
Eye Protection:EYE GLASSES WITH SIDE SHIELDS OR GOGGLES
Other Protective Equipment:EMERGENCY SHOWERS AND EYE WASH STATIONS
SHOULD BE MADE AVAILABLE. EDUCATE AND TRAIN EMPLOYEES IN THE SAFE
USE AND HANDLING OF THIS PRODUCT. FOR SKIN PROTECTION USE CHEMICAL
RESISTANT APRONS.
Supplemental Safety and Health
PART A OF A 4 PART KIT, SAME NSN.
Chemical Properties
HCC:B3
Boiling Pt:=100.C, 212.F
B.P. Text:APPROX.
Melt/Freeze Pt:=0.C, 32.F
M.P/F.P Text:APPROX.
Spec Gravity:APPROX. 1.09
pH:10 -10.4
Solubility in Water:SOLUBLE
Appearance and Odor:CLEAR LIGHT YELLOW LIQUID; ODORLESS
Stability
Stability Indicator/Materials to Avoid:YES
STRONG ACIDS, OXIDIZERS.
Stability Condition to Avoid:NONE KNOWN.
Hazardous Decomposition Products:IN CASE OF FIRE, OXIDES OF SULFUR,
CO2, CARBON MONOXIDE AND OTHER POTENTIALLY TOXIC FUMES.
Conditions to Avoid Polymerization:WILL NOT OCCUR.
Disposal
Waste Disposal Methods:RECOVER NONUSABLE FREE LIQUID AND/OR
CONTAMINATED WATER, AND DISPOSE OF IN AN APPROVED AND PERMITTED
TREATMENT SYSTEM. REMOVE NONUSABLE SOLID MATERIAL AND/OR
CONTAMINATED SOIL, FOR DISPOSAL IN AN APPR OVED AND PERMITTED
LANDFILL. DISCHARGE TO SEWER MAY REQUIRE APPROVAL OF PERMITTING
AUTHORITY AND MAY REQUIRE PRETREATMENT.
Toxicology
Toxicological Information:HYDROQUINONE: LD50 ORAL RAT = 320 MG/KG, SKIN
EFFECTS: 2% - MILD (HUMAN), 5% - SEVERE (HUMAN). ORAL LDL0 (HUMAN)
= 29 MG/KG. CHRONIC TOXICITY: ADVERSE KIDNAY EFFECTS HAVE BEEN
OBSERVED PRIMARILY IN O NE STRAIN OF MALE RAT (F-344) FOLLOWING
CHRONIC ADMINISTRATION OF ORAL DOSES. CARCINOGENICITY: FORMATION OF
BENIGN KIDNEY TUMORS OCCURRED ONLY AFTER NEPHROPATHY DEVELOPED AND
ONLY IN ONE STRAIN OF MAL E RATS. MUTAGENICITY: AMES TEST WAS
NEGATIVE. DEVELOPMENTAL TOXICITY:HAS NOT CAUSED BIRTH DEFECTS.
REPRODUCTIVE EFFECTS: HAS NOT CAUSED REPRODUCTIVE EFFECTS IN MALE
AND FEMALE ANIMALS.
Other Information
Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ecology
Ecological:NO INFO AVAILABLE.
Transport
Transport Information:NOT REGULATED BY ALL MODES OF TRANSPORTATION.
Regulatory
SARA Title III Information:SEC 302 EHS: HYDROQUINONE 5-10%. SEC 311/312
HAZ CATEGORIES: IMMEDIATE AND DELAYED HEALTH HAZARDS. SEC 313 TOXIC
CHEMICALS:HYDROQUINONE 5-10%. RCRA STATUS: IF RELEASED IN ITS
PURCHASED FORM, THIS PROD UCT WOULD NOT BE A HAZARDOUS WASTE EITHER
BY LISTING OR BY CHARACTERISTICS.
Federal Regulatory Information:TSCA INVENTORY STATUS: IS LISTED ON THE
TSCA INVENTORY. OSHA STATUS: THIS PRODUCT IS HAZARDOUS UNDER THE
CRITERIA OF THE FEDERAL OSHA HAZARD COMMUNICATION STANDARD 29 CFR
1910.1200.
State Regulatory Information:INGREDIENTS ARE LISTED BY THE FOLLOWING
STATES: NJ, PA, MA.